Robert E. Rydell
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Carcinogens and Genotoxicity Assessment 10
-
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Risa B. Mann (1 shared paper)Costan W. Berard (1 shared paper)Richard S. Neiman (1 shared paper)John M. Bennett (1 shared paper)Maurice P Barcos (1 shared paper)Hugh Bonner (1 shared paper)Frederick W. Hoffbauer (1 shared paper)Martin M. Oken (7 shared papers)
- Journals
- JNCI Journal of the National Cancer Institute (3 papers)American Journal of Hematology (2 papers)The American Journal of Medicine (2 papers)British Journal of Haematology (2 papers)Cancer (2 papers)
- Partner nations
- United States
In The Last Decade
Robert E. Rydell
22 papers receiving 1.6k citations
Robert E. Rydell's Hit Papers
Peers
Comparison fields: 5 of 69
- Hematology 1.1k
- Genetics 182
- Hepatology 130
- Cancer Research 114
- Pharmacology 73
Countries citing papers authored by Robert E. Rydell
This map shows the geographic impact of Robert E. Rydell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Rydell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Rydell more than expected).
Fields of papers citing papers by Robert E. Rydell
This network shows the impact of papers produced by Robert E. Rydell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Rydell. The network helps show where Robert E. Rydell may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Rydell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases Hit paper breakdown → | 1981 | 799 |
| 2 | 1988 | 198 | |
| 3 | 1956 | 185 | |
| 4 | 1980 | 121 | |
| 5 | 1983 | 118 | |
| 6 | 1991 | 85 | |
| 7 | 1973 | 67 | |
| 8 | On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat. | 1972 | 57 |
| 9 | Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. | 1992 | 28 |
| 10 | Structure-activity relationships of N-acylarylhydroxylamines in the rat. | 1970 | 27 |
| 11 | 1986 | 27 | |
| 12 | 1980 | 20 | |
| 13 | Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates. | 1977 | 19 |
| 14 | 1978 | 19 | |
| 15 | 1981 | 18 | |
| 16 | Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids. | 1973 | 17 |
| 17 | 1973 | 11 | |
| 18 | Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo. | 1971 | 10 |
| 19 | The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles. | 1975 | 10 |
| 20 | 1978 | 6 |
About Robert E. Rydell
Robert E. Rydell is a scholar working on Cancer Research, Hematology, Genetics, Pharmacology and Hepatology, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (10 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Acute Lymphoblastic Leukemia research (1 paper), Vascular Anomalies and Treatments (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Hematology (1.1k citations), Genetics (182 citations), Hepatology (130 citations), Cancer Research (114 citations) and Pharmacology (73 citations). Robert E. Rydell has collaborated with scholars based in United States. Frequent co-authors include Risa B. Mann, Costan W. Berard, Richard S. Neiman, John M. Bennett, Maurice P Barcos, Hugh Bonner, Frederick W. Hoffbauer, Martin M. Oken, Kathy Foucar and Danuta Malejka‐Giganti. Their work appears in journals such as JNCI Journal of the National Cancer Institute, American Journal of Hematology, The American Journal of Medicine, British Journal of Haematology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.